The Beauty Health Company (SKIN) Misses Q2 EPS by 2c, beats revenue, offers guidance

The Beauty Health Company (NASDAQ: SKIN) reported Q2 EPS of $0.03, $0.02 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $117.5 million versus the consensus estimate of $114.89 million.

GUIDANCE:

The Beauty Health Company sees Q3 2023 revenue of $460-480 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
• Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue